BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32096063)

  • 41. Computed Tomography Versus Magnetic Resonance in Head and Neck Cancer: When to Use What and Image Optimization Strategies.
    Juliano A; Moonis G
    Magn Reson Imaging Clin N Am; 2018 Feb; 26(1):63-84. PubMed ID: 29128007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defining secure surgical bone margins in head and neck squamous cell carcinomas: The diagnostic impact of intraoperative cytological assessment of bone resection margins compared with preoperative imaging.
    Nieberler M; Stimmer H; Rasthofer D; Nentwig K; Weirich G; Wolff KD
    Oral Oncol; 2020 Mar; 102():104579. PubMed ID: 32062159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
    Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinoma of Unknown Primary and the 8th Edition TNM Classification for Head and Neck Cancer.
    Boeker R; Stromberger C; Heiland M; Beck-Broichsitter B; Hofmann VM; Neumann K; Ochsenreither S; Olze H; Dommerich S; Piwonski I; Coordes A
    Laryngoscope; 2021 Sep; 131(9):E2534-E2542. PubMed ID: 33734438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Addition of tumour infiltration depth and extranodal extension improves the prognostic value of the pathological TNM classification for early-stage oral squamous cell carcinoma.
    Boeve K; Melchers LJ; Schuuring E; Roodenburg JL; Halmos GB; van Dijk BA; van der Vegt B; Witjes MJ
    Histopathology; 2019 Sep; 75(3):329-337. PubMed ID: 31021008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiological detection of extracapsular spread in head and neck squamous cell carcinoma (HNSCC) cervical metastases.
    Url C; Schartinger VH; Riechelmann H; Glückert R; Maier H; Trumpp M; Widmann G
    Eur J Radiol; 2013 Oct; 82(10):1783-7. PubMed ID: 23751931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy.
    Rovira A; Tornero J; Taberna M; Oliva M; Montal R; Nogues J; Mari A; Viñals JM; Lozano A; Maños M; Mesia R
    J Laryngol Otol; 2021 Nov; 135(11):970-975. PubMed ID: 34482849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma.
    Chung MS; Choi YJ; Kim SO; Lee YS; Hong JY; Lee JH; Baek JH
    AJNR Am J Neuroradiol; 2019 Jun; 40(6):1049-1054. PubMed ID: 31072971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis.
    Henson CE; Abou-Foul AK; Morton DJ; McDowell L; Baliga S; Bates J; Lee A; Bonomo P; Szturz P; Nankivell P; Huang SH; Lydiatt WM; O'Sullivan B; Mehanna H
    Front Oncol; 2023; 13():1263347. PubMed ID: 37799466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma.
    Kwon M; Roh JL; Lee J; Cho KJ; Choi SH; Nam SY; Kim SY
    J Craniomaxillofac Surg; 2015 Jul; 43(6):769-78. PubMed ID: 26027870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role and responsibility of multimodal imaging in head and neck cancer].
    Gõdény M
    Magy Onkol; 2013 Sep; 57(3):182-202. PubMed ID: 24107825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    Toya R; Saito T; Matsuyama T; Kai Y; Shiraishi S; Murakami D; Yoshida R; Watakabe T; Sakamoto F; Tsuda N; Arimura H; Orita Y; Nakayama H; Oya N
    Anticancer Res; 2020 Apr; 40(4):2073-2077. PubMed ID: 32234899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of extranodal extension detected by computed tomography for predicting clinical response after chemoradiotherapy in head and neck squamous cell cancer.
    Moon H; Choi YJ; Lee YS; Lee SW; Kim SB; Roh JL; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2018 Apr; 138(4):392-399. PubMed ID: 29105549
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
    Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA
    Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.